Introduction
Lithium (Greek, meaning Stone) was discovered by Arfwedson in 1811 [1] . Lithium carbonate (Li 2 CO 3 ), salt form of lithium, is commonly used as a psychiatric medication for the treatment of mania, both acutely and in the long term. [2, 3] The therapeutic uses of lithium also include as an augmenting agent in depression, schizoaffective disorder, aggression, impulse control disorder, eating disorders, attention deficit disorder and in certain subsets of alcoholism. Lithium has been used in many medical disorders, especially cluster headache and dermatological disorders (seborrheic dermatitis, eczematoid dermatitis, and genital herpes). [4] Initially, lithium was used to treat Urinary calculi and gout with little success [5] , till Cade, J. (1949) [6] reported its antimanic effect. Lithium belongs to alkali group of metals, having atomic no.3 and atomic weight of 6.93. It is water soluble, non protein bound and is distributed in all body fluids. [7] Lithium is readily absorbed after oral administration and its peak level is reached in 2-4 hrs. About 95% of absorbed lithium carbonate is excreted in urine; about 1% in feces and 4-5 % in sweat. [8, 2] Lithium binds poorly to high and low molecular weight plasma proteins but binds strongly to very low molecular weight legands. [9] As it moves slowly from extracellular compartment to intracellular space, it may require 6-8 days to reach steady blood concentration and desired therapeutic responses. [2] Distribution of lithium in the human organs is almost uniform; it is concentrated in tissues like brain, kidney, thyroid, bone, liver, and muscle cells against concentration gradient.
[2] Lithium becomes widely distributed in the central nervous system and interacts with a number of neurotransmitters, decreasing norepinephrine release and increasing serotonin synthesis. It has been reported that lithium can alter the glucose metabolic set point [10] and inhibits the phosphoglucomutase. [11] An increase in fructose 2, 6-biphophate levels had been observed with lithium treatment but it does not affect the cytochrome P-450. [12] 1.1
Aim of the study: Lithium carbonate is widely used to treat maniac depressive psychosis. As the therapy is prolonged one, it is unlikely to be without undesirous side effects on various organs including the highly metabolic organ, the liver. The present study is aimed to analyze the histological changes that occur in liver on prolonged use of Lithium in Albino rats and try to correlate these findings to human beings.
II. Material and Methods
After institutional Animal Ethics Committee approval, 60 Albino Rats (average weight 150 gm) were housed under uniform husbandry conditions. The rats were divided in two groups: Group A (control group) of 15 rats were fed with routine diet and water ad. Libitum, Group B: this group of 45 rats was fed with routine diet, water and pellets of flour mixed with lithium carbonate. The animals of two groups were kept in different cages labeled (A) and (B). Dose of the drug: -Dose of the drug was calculated by converting adult human therapeutic dose (600-2400mg /day) to animal dose. [7, 13] The average dose of lithium carbonate amounted to 30mg / kg of weight of rats per day. To study the effects of the drug, five rats from group (A) i.e. control group and 15 rats from group (B) i.e. drug treated group were sacrificed at intervals of four, eight and twelve weeks. The animals were anesthetized with chloroform, a midline incision was given on the anterior abdominal wall, muscles retracted, liver excised, and preserved in 10% formalin. The tissues were processed by standard histological technique; 5µm thick sections were prepared, stained with Haematoxylin and Eosin stain, observed under compound light microscope and observations recorded.
III. Observations
Control group Animals of control group remained healthy and active throughout the experiment. No pathological changes were noticed on gross or microscopic examination of liver and heart of animals of control group. Drug treated group On gross examination, it was observed that surface of liver was smooth and soft in control group, but in drug treated animals the consistency was firm. The liver showed change in color from reddish brown in control group to greyish in drug treated group. Some of the drug treated animals showed 1-2 cysts in their liver. (Fig.1 ) Histological examination of liver (table no. 1) revealed intact capsule in all the animals. Microscopic changes were evident after eight weeks of drug treatment. The drug treated animals showed hepatic degenerations like indistinct cell outlines, loss of normal architecture of hepatocytes and nuclear degeneration at 8weeks of drug treatment. As the duration of exposure to drug increased, the hepatic degeneration finally led to necrosis in 20% of animals ( fig.2 ). The hepatic cords were distorted; the sinusoids dilated. Portal tracts were infiltrated with lymphocytes, plasma cells and kupffer cells, known as portal-triaditis. Portal triaditis occurred in 20% animals at 4 weeks, which increased to 40% at 8 weeks and 60% at 12weeks. Lymphocytic infiltration was also observed in hepatic parenchyma which was not breaking the limiting plate and gave the appearance of chronic persistent hepatitis in latter stages of drug treatment. Bile duct proliferation was noticed in portal areas. The central veins were dilated and congested. There was sinusoidal congestion at 8 weeks of drug treatment which resulted in sinusoidal hemorrhages in 20% of animals at 12 weeks. (fig.3 ) 
IV. Discussion
Since lithium carbonate is highly effective in controlling and preventing recurring manic depressive episodes, its use in psychiatry to rehabilitate patients continues despite its complications. [14] Structural and functional effects of lithium carbonate have been studied by various workers from time to time, [15] [16] [17] but effects of lithium carbonate on the microanatomy of liver have not received much attention.
In the present study, on gross examination, a gradual decrease in weight of liver was noticed as the duration of drug treatment increased. The surface of the liver was firm and colour changed from reddish brown to greyish. In addition, white spots on the surface of liver were noticed, which inside were corresponding to cysts.
Microscopically, the hepatocytes showed indistinct cell outline, some of them showed marked cytoplasmic and nuclear degeneration with loss of normal architecture. Focal areas of necrosis were followed by cyst formation. The Sinusoidal spaces increased and there was Kupffer cell hyperplasia. There was also periportal lymphoplasmacytic infiltration known as portal triaditis. The central veins were congested and there were hemorrhages in the sinusoids. Similar changes were observed by Shah et al.
[i8] On section of the cyst, the cyst wall consisted of degenerative hepatocytes and the cavity of the cyst contained hemorrhagic fluid. Sharief et al [7] studied the adverse effect of withdrawal of chronic lithium therapy on livers of rabbits and found cholangitis, central veins congested and lymphocytic infiltration of the liver parenchyma, supporting the findings of the present study. They did not report any derangement of the hepatic architecture, but in the present study there was cytoplasmic and nuclear degeneration, followed by necrosis and cyst formation. They also reported development of cholangiocarcinoma in the rabbits after 4 weeks of lithium therapy, no such development was observed in the present study, may be because in the present study we used therapeutic dose of lithium carbonate, whereas Sharief et al [7] used double the therapeutic dose in their study. The hepatotoxicity of lithium carbonate has been explained on the basis of two independent mechanisms: 1.
Biotransformation of the drug in the liver with the formation of toxic metabolites.
2.
Induction of an allergic hypersensitivity reaction. [19] The former mechanism seems to be working in this experimental study rather than the other one as no allergic infiltrate like eosinophils was observed in liver parenchyma. Similar hepatic changes in laboratory animals could also be observed by dose dependent effect of directly acting therapeutic agents. Both inflammatory and congestive changes had also been reported in liver of lithium treated animals. [20] 
V. Conclusion
From the above discussion it can be concluded that liver undergoes structural derangement with prolonged treatment with Lithium Carbonate. Main effects on liver are:- Indistinct cell outline  Cytoplasmic and nuclear derangement  Focal areas of necrosis with cyst formation  Increase in space of sinusoids with hyperplasia of Kupffer Cells lining the sinusoids.  Periportal lymphoplasmacytic cell infiltration.  Congestion and Dilatation of central veins. 
